{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:49:24Z","timestamp":1772120964047,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jaad.2009.11.588","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T04:22:36Z","timestamp":1279686156000},"page":"815-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions"],"prefix":"10.1016","volume":"63","author":[{"given":"Julia S.","family":"Lehman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer N.","family":"Kalaaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.11.588_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.99.1.143","article-title":"Pulmonary complications of combination therapy with cyclophosphamide and prednisone","volume":"99","author":"Sen","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2009.11.588_bib2","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.11.588_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.24283","article-title":"Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients","volume":"61","author":"Komano","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2009.11.588_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0190-9622(98)70088-X","article-title":"Pneumocystis carinii pneumonia complicating methotrexate treatment of pityriasis rubra pilaris","volume":"39","author":"Duncan","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00535-004-1454-2","article-title":"Pneumocystis carinii pneumonia in patients with ulcerative colitis","volume":"39","author":"Takenaka","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.11.588_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.2000.03756.x","article-title":"Pneumocystis carinii pneumonia in a patient with pyoderma gangrenosum treated with cyclosporin","volume":"143","author":"De Silva","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1445-5994.2007.01382.x","article-title":"Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period","volume":"37","author":"Meuli","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaad.2009.11.588_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/00365540601071867","article-title":"Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab","volume":"39","author":"Kalyoncu","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaad.2009.11.588_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S0036-46652005000500012","article-title":"Severe pneumocystis pneumonia in a renal transplant recipient after long term mycophenolate mofetil treatment","volume":"47","author":"Totet","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jaad.2009.11.588_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0036-46652005000300005","article-title":"Mycophenolate mofetil may protect against Pneumocystis carinii pneumonia in renal transplanted patients","volume":"47","author":"Azevedo","year":"2005","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jaad.2009.11.588_bib12","first-page":"199","article-title":"Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus","volume":"23","author":"Podrebarac","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.11.588_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.1999.03052.x","article-title":"Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases","volume":"141","author":"Raychaudhuri","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaad.2005.11.1054","article-title":"Medical pearl: pneumocystis pneumonia prophylaxis for patients on chronic systemic corticosteroids","volume":"55","author":"Lemaire","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2009.07.042","article-title":"Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications","volume":"62","author":"Gerhart","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/archinte.1997.00440340145015","article-title":"Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis","volume":"157","author":"Bachelez","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2009.11.588_bib18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2133.2002.494412.x","article-title":"Pneumocystis carinii pneumonia in a patient on immunosuppressive drugs for pyoderma gangrenosum","volume":"147","author":"McGarry","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib19","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.143.9.1224","article-title":"Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma","volume":"143","author":"Maronn","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4065\/79.2.243","article-title":"Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas","volume":"79","author":"Aviles","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.11.588_bib21","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaad.2009.11.588_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/RHU.0b013e31817a7e30","article-title":"Prophylactic antibiotic usage for Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature","volume":"14","author":"Gupta","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/s10165-006-0502-6","article-title":"Evaluation of pneumocystis pneumonia infection risk factors in patients with connective tissue disease","volume":"16","author":"Iikuni","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-008-0721-6","article-title":"Risk factors of Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus","volume":"29","author":"Lertnawapan","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2009.11.588_bib25","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus","volume":"23","author":"Kadoya","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2009.11.588_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203302lu243oa","article-title":"Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications","volume":"11","author":"Badsha","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2009.11.588_bib28","first-page":"46","article-title":"Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus","volume":"6","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2009.11.588_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-120-11-199406010-00006","article-title":"Prophylaxis for opportunistic infections in patients with HIV infection","volume":"120","author":"Gallant","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2009.11.588_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.11.588_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00296-007-0505-4","article-title":"Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease","volume":"28","author":"Kimura","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2009.11.588_bib32","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1001\/jama.286.19.2450","article-title":"New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia","volume":"286","author":"Kovacs","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.11.588_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","article-title":"A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity","volume":"15","author":"Jick","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2009.11.588_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2009.11.588_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/s10165-008-0037-0","article-title":"Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy","volume":"18","author":"Mori","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"Festic","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2009.11.588_bib37","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2009.11.588_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rhu.0000221794.24431.36","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"12","author":"Li","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2009.11.588_bib40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.11.588_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib42","first-page":"289","article-title":"Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome","volume":"13","author":"Thomas","year":"1998","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.jaad.2009.11.588_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/PL00021707","article-title":"Prediction of and prophylaxis against pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy","volume":"15","author":"Ogawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2009.11.588_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1099\/jmm.0.45528-0","article-title":"Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens","volume":"53","author":"Flori","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jaad.2009.11.588_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1529-8019.2002.01544.x","article-title":"Prophylaxis in dermatologic patients receiving immunosuppressive therapy","volume":"15","author":"Rencic","year":"2002","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209021124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209021124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:17:15Z","timestamp":1759270635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209021124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0190962209021124"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.11.588","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5957956.5957054","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.11.588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}